日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

针对TP53突变相关新抗原的双特异性抗体和CAR T细胞表现出不一致的亲和力要求。

DiNapoli Sarah R, Wright Katharine M, Mog Brian J, Pearlman Alexander H, Nichakawade Tushar D, Marcou Nikita, Hsiue Emily Han-Chung, Hwang Michael S, Douglass Jacqueline, Liu Qiang, Watson Evangeline, Dal Molin Marco, Cohen Joshua D, Popoli Maria, Paul Suman, Konig Maximilian F, Wyhs Nicolas, Azurmendi P Aitana, Glavaris Stephanie, Ge Jiaxin, Awosika Tolulope O, Liu Jin, Gabrielson Kathleen L, Gabelli Sandra B, Pardoll Drew M, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Zhou Shibin, Vogelstein Bert

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

临床前研究表明,Co-STARs 结合了嵌合抗原和 T 细胞受体的优势,可用于治疗抗原密度低的肿瘤

Mog Brian J, Marcou Nikita, DiNapoli Sarah R, Pearlman Alexander H, Nichakawade Tushar D, Hwang Michael S, Douglass Jacqueline, Hsiue Emily Han-Chung, Glavaris Stephanie, Wright Katharine M, Konig Maximilian F, Paul Suman, Wyhs Nicolas, Ge Jiaxin, Miller Michelle S, Azurmendi P, Watson Evangeline, Pardoll Drew M, Gabelli Sandra B, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Zhou Shibin